THB Asset Management’s Regenxbio RGNX Stock Holding History

THB Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,437	Closed	-$426K	–	167
2019 Q1	$426K	Buy	+7,437	New	+$368K	0.06%	144

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

THB Asset Management's RGNX Position: Q2 2019 in Review

THB Asset Management sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 7,437 shares — an estimated $426K sold.

THB Asset Management first reported a position in RGNX in Q1 2019 and held it in 1 quarter. The position peaked at $426K in Q1 2019. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

THB Asset Management reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
THB Asset Management sold 7,437 Regenxbio shares in Q2 2019, an estimated $426K.
THB Asset Management first reported a position in Regenxbio in Q1 2019 and held it in 1 quarter.
THB Asset Management's Regenxbio position peaked at $426K in Q1 2019.
186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on THB Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.